×
Entrez Id:
4204
Gene Symbol:
MECP2
MECP2
0.110
Biomarker
disease
BEFREE
Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice.
26806603
2016
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.110
Biomarker
disease
BEFREE
Neuropathological investigation revealed enlarged ventricles, marked cerebral cortical atrophy and Purkinje cell loss, less-prominent cerebellar and pontine atrophy, and neuronal intranuclear ubiquitin-positive inclusions, consistent with Marinesco bodies, which did not stain for long polyglutamine tracts, alpha-synuclein , tau, or transactive response DNA-binding protein 43.
26340331
2015
×
Entrez Id:
5663
Gene Symbol:
PSEN1
PSEN1
0.110
GeneticVariation
disease
BEFREE
To investigate whether a similar pattern of cortical atrophy is present in presymptomatic presenilin 1 E280A mutation carriers an average of 6 years before clinical symptom onset.
23134660
2013
×
Entrez Id:
170302
Gene Symbol:
ARX
ARX
0.110
GeneticVariation
disease
BEFREE
ARX mutation testing should be undertaken in children aged less than 1 year with Ohtahara syndrome and a movement disorder, and in infants with unexplained neurodegeneration, progressive white matter loss, and cortical atrophy .
19747203
2010
×
Entrez Id:
2896
Gene Symbol:
GRN
GRN
0.110
GeneticVariation
disease
BEFREE
Cortical atrophy and language network reorganization associated with a novel progranulin mutation.
19020205
2009
×
Entrez Id:
5521
Gene Symbol:
PPP2R2B
PPP2R2B
0.110
Biomarker
disease
BEFREE
SCA-12 : Tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion.
11171892
2001
×
Entrez Id:
5663
Gene Symbol:
PSEN1
PSEN1
0.110
Biomarker
disease
HPO
×
Entrez Id:
2896
Gene Symbol:
GRN
GRN
0.110
Biomarker
disease
HPO
×
Entrez Id:
5521
Gene Symbol:
PPP2R2B
PPP2R2B
0.110
Biomarker
disease
HPO
×
Entrez Id:
4204
Gene Symbol:
MECP2
MECP2
0.110
Biomarker
disease
HPO
×
Entrez Id:
170302
Gene Symbol:
ARX
ARX
0.110
Biomarker
disease
HPO
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.110
Biomarker
disease
HPO
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.100
Biomarker
disease
BEFREE
The model shows that, for instance, APOE carriers have a significantly higher pace of cortical atrophy but not earlier atrophy onset.
29780348
2018
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.100
GeneticVariation
disease
BEFREE
Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
29278888
2018
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.100
Biomarker
disease
BEFREE
We identified the prevalence of APOE -ε4 and evaluated its association with cortical atrophy .
30511009
2018
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.100
Biomarker
disease
BEFREE
As the detrimental effects of APOE4 seen in older AD patients were not found in younger AD patients, we suggest that some unrevealed factors are associated with cortical atrophy and non-amnestic cognitive dysfunction in young AD with APOE4 noncarriers.
29376853
2018
×
Entrez Id:
4576
Gene Symbol:
TRNT
TRNT
0.100
CausalMutation
disease
CLINVAR
CO2 -sensitive tRNA modification associated with human mitochondrial disease.
29760464
2018
×
Entrez Id:
4576
Gene Symbol:
TRNT
TRNT
0.100
CausalMutation
disease
CLINVAR
Mutation m.15923A>G in the MT-TT gene causes mild myopathy - case report of an adult-onset phenotype.
30236074
2018
×
Entrez Id:
8506
Gene Symbol:
CNTNAP1
CNTNAP1
0.100
GeneticVariation
disease
CLINVAR
Novel mutation in CNTNAP1 results in congenital hypomyelinating neuropathy.
27668699
2017
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.100
Biomarker
disease
BEFREE
Higher CAIDE Dementia Risk Score (version without APOE ) was significantly associated with higher total tau, more severe MTA, WMC, and global cortical atrophy -frontal subscale.
27143429
2016
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.100
Biomarker
disease
BEFREE
Compared to HC, APOE ε 4 carriers presented cortical atrophy in right cingulate gyrus (R_CG) (GMV: APOE carriers: 8475.23 ± 1940.73 mm3, HC: 9727.34 ± 1311.57 mm3, t = 2.314, p = 0.026, corrected) and left insular (GMT: APOE ε 4 carriers: 3.83 ± 0.37 mm, HC: 4.05 ± 0.25 mm, t = 2.197, p = 0.033, corrected).
27097839
2016
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.100
Biomarker
disease
BEFREE
Asymmetry of cortical atrophy and normal APOE ε4 prevalence constitute deviations from typical AD.
27566743
2016
×
Entrez Id:
4576
Gene Symbol:
TRNT
TRNT
0.100
CausalMutation
disease
CLINVAR
New mitochondrial DNA mutations in tRNA associated with three severe encephalopamyopathic phenotypes: neonatal, infantile, and childhood onset.
22638997
2012
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.100
GeneticVariation
disease
BEFREE
In conclusion, in our sample CI was associated with higher subcortical damage and cortical atrophy but not with APOE -epsilon4 genotype.
19965518
2009
×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.100
GeneticVariation
disease
BEFREE
Our aim was to define the relationship between APOE epsilon4 allele load and regionally-specific brain cortical atrophy in Alzheimer's Disease (AD).
19013250
2009